The Therapeutic Goods Administration (TGA) has provisionally approved the use of the Moderna COVID-19 vaccine for children aged between 12 and 17.
The move follows the vaccine being provisionally approved for Australians over the age of 18 on August 9.
Children are also recommended to have two doses given 27 days apart.
READ MORE: Queensland won't go into lockdown over four-year-old with coronavirus
"Provisional approval for use in the 12-17 years age group has been made following careful evaluation of the available data supporting safety and efficacy," the TGA said in a statement.
"The vaccine has also received regulatory approval or authorisation in this age group in several jurisdictions, including the United Kingdom, Canada, the European Union and Switzerland."
The TGA said the Moderna vaccine has shown "strong efficacy preventing symptomatic COVID-19 and severe COVID-19 in clinical trials".
"The Australian Government has secured 25 million doses of Spikevax (elasomeran) to further diversify Australia's vaccine portfolio as well as provide access to a booster or variant vaccine should this be required in the future," the TGA said.
Health Minister Greg Hunt described Moderna as "the next vaccine to save lives".
from 9News https://ift.tt/2VdlrnR
via IFTTT
0 Comments